We found that PLAD also significantly increased the proportion of antigen-presenting dendritic cells (DC1) and decreased the proportion of conventional dendritic cells (DC2) (Figure 5A-B), suggesting a beneficial effect on antitumor immunity since DC2 are often tolerogenic in cancer while DC1 mediate antigen recognition and activation of T cells. Here, ZDHHC4 is linked to cancer.